A possible explanation for the synergism might be enhanced phosphorylation levels of AKT due to palbociclib treatment, as, for example, observed in breast cancer, osteosarcoma, and glioblastoma cell lines [26,27,28,29]. This evidence concerns the gene AKT1 and breast carcinoma.